Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes

Clinical trial NCT03818581 · COMPLETED

Trial details

NCT number: NCT03818581
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Insomnia Sleep Disorder Inflammation

Start date: 2019-03-15
Primary completion: 2021-11-03
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.